Algeria vs El Salvador: Protecting minority investors (DB06-14 methodology) - Score
Algeria
30
in 2013
El Salvador
30
in 2013
Algeria rank
168th
El Salvador rank
168th
Protecting minority investors (DB06-14 methodology) - Score over time
- Algeria
- El Salvador
How they compare
Algeria currently reports 30 against 30 in El Salvador, a difference of 0.
The two have swapped places 1 time across 9 shared years of data; in 2005 it was Algeria ahead.
Algeria ranks 168th and El Salvador ranks 168th of 191 countries.
Algeria has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Algeria | El Salvador | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 30 | 26.67 | 3.33 | Algeria |
| 2010s | 30 | 29.17 | 0.8333 | Algeria |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher protecting minority investors (db06-14 methodology) - score, Algeria or El Salvador?
- Algeria, at 30 against 30 in El Salvador as of 2013.
- What is the difference in protecting minority investors (db06-14 methodology) - score between Algeria and El Salvador?
- 0, with Algeria ahead.
- How many years of comparable data are there for Algeria and El Salvador?
- 9 years are reported by both, from 2005 to 2013.
- How do Algeria and El Salvador rank globally for protecting minority investors (db06-14 methodology) - score?
- Algeria ranks 168th and El Salvador ranks 168th of 191 countries.
- Where does this data come from?
- The World Bank, published as Protecting minority investors (DB06-14 methodology) - Score. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The score for protecting minority investors benchmarks economies with respect to the regulatory best practice on the indicator set. The score is indicated on a scale from 0 to 100, where 0 represents the worst regulatory performance and 100 the best regulatory performance, and is computed based on the methodology in the DB06-14 studies.